Alphabetical Search: 1 2 3 4 5 6 7 8 9 A B C D E F G H I K M N P T U X
  Searchbox: Selection of cyclic nucleotides by properties.
Subcategories for Cyclic Nucleotides
PDE- resistant PKA Inhibitors
PDE- resistant PKA Activators
Epac Agonists
Epac- negative Controls
Other PKA Activators
PDE- resistant PKG Inhibitors
PDE- resistant PKG Activators
Other Activators of PKG
Affinity Gels
cAMP Ligands for Immobilization
cGMP Ligands for Immobilization
Caged Cyclic Nucleotides
Special Task Cyclic Nucleotides
Modulators of CNG Ion Channels
Fluorescent Cyclic Nucleotides
Peptide-based PKG Inhibitors
Metabolically activatable cNMP
cNMP with Pyrimidine Nucleobase
Classification
Bulk
cAMP modified at the exocyclic oxygen - equatorial (Rp-)
cAMP modified at the exocyclic oxygen - axial (Sp-)
cGMP modified at the exocyclic oxygen - equatorial (Rp-)
cGMP modified at the exocyclic oxygen - axial (Sp-)
Position of Purine Nucleobase Modification:
Description:
Lipophilicity

Lipophilicity ranking is based on log kw data. To be membrane-permeant, analogues should have a log kw of at least 1.2

<< Back
Forgot your password?
Register
Username:
Password:
What is new!

December 21, 2009

(D)-DT-2 - New peptidic inhibitor of PKG I alpha !

The highly potent and selective PKG inhibitor peptide (D)-DT-2 (Cat. No. D 110) has become availa... [more...]

December 15, 2009

c-diGMP - New size !

We are pleased to announce a significant price reduction for the bacterial second messenger cycli... [more...]